Chronic cyclosporin A (CsA) nephrotoxicity in the rat

The effect of calcium blockade with verapamil

M. G. Shaikh, S. D. Heys, P. A.J. Brown, P. H. Whiting*

*Corresponding author for this work

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Renal structure and function were assessed in groups of male Sprague-Dawley rats, either surgically intact (SI) or nephrectomized (N), treated with either CsA alone (20 mg/kg, p.o.) or in combination with verapamil (VER; 10 mg/kg/day, i.p.) daily for up to 28 days. Compared to vehicle treated controls, reduced creatinine clearance rates (CCR, mean ± s.e.m.) were noted following CsA treatment in SI animals on days 21 and 28 (279 ± 4 vs 196 ± 20 and 296 ± 13 vs 122 ± 13 ml/h/kg, respectively, both P < 0.05). However, CCR was around 60% of pretreatment values in all N animals from day 7 onwards. A two to three-fold elevation in urinary N-acetyl-β-D-glucosaminidase activity was noted from day 7 to 28 in all CsA treated animals. In addition, a similar severity of both renal tubular basophilia and corticomedullary microcalcification (but not proximal tubular vacuolation), was noted at all time points in animals receiving CsA alone. Co-treatment with VER reduced the severity of microcalcification in CsA groups, particularly N animals, increased CCR on day 14 in the SI (196 ± 23 vs 391 ± 64) and days 21 and 28 in N (141 ± 14 vs 357 ± 32 and 152 ± 28 vs 261 ± 20) groups, respectively but had no effect on the magnitude of enzymuria, despite significantly increased trough whole blood CsA levels (20-30%) in both SI and N groups. These results indicate that calcium blockade reduces both structural and functional features of chronic CsA nephrotoxicity.

Original languageEnglish
Pages (from-to)389-396
Number of pages8
JournalInternational journal of experimental pathology
Volume74
Issue number4
Publication statusPublished - Aug 1993

Fingerprint

Verapamil
Cyclosporine
Calcium
Calcinosis
Kidney
Hexosaminidases
Sprague Dawley Rats
Creatinine

Keywords

  • calcium blockade
  • cyclosporin A
  • nephrotoxicity
  • rat

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Chronic cyclosporin A (CsA) nephrotoxicity in the rat : The effect of calcium blockade with verapamil. / Shaikh, M. G.; Heys, S. D.; Brown, P. A.J.; Whiting, P. H.

In: International journal of experimental pathology, Vol. 74, No. 4, 08.1993, p. 389-396.

Research output: Contribution to journalArticle

Shaikh, M. G. ; Heys, S. D. ; Brown, P. A.J. ; Whiting, P. H. / Chronic cyclosporin A (CsA) nephrotoxicity in the rat : The effect of calcium blockade with verapamil. In: International journal of experimental pathology. 1993 ; Vol. 74, No. 4. pp. 389-396.
@article{4a3597221fd34b6eb1f1053a7b418104,
title = "Chronic cyclosporin A (CsA) nephrotoxicity in the rat: The effect of calcium blockade with verapamil",
abstract = "Renal structure and function were assessed in groups of male Sprague-Dawley rats, either surgically intact (SI) or nephrectomized (N), treated with either CsA alone (20 mg/kg, p.o.) or in combination with verapamil (VER; 10 mg/kg/day, i.p.) daily for up to 28 days. Compared to vehicle treated controls, reduced creatinine clearance rates (CCR, mean ± s.e.m.) were noted following CsA treatment in SI animals on days 21 and 28 (279 ± 4 vs 196 ± 20 and 296 ± 13 vs 122 ± 13 ml/h/kg, respectively, both P < 0.05). However, CCR was around 60{\%} of pretreatment values in all N animals from day 7 onwards. A two to three-fold elevation in urinary N-acetyl-β-D-glucosaminidase activity was noted from day 7 to 28 in all CsA treated animals. In addition, a similar severity of both renal tubular basophilia and corticomedullary microcalcification (but not proximal tubular vacuolation), was noted at all time points in animals receiving CsA alone. Co-treatment with VER reduced the severity of microcalcification in CsA groups, particularly N animals, increased CCR on day 14 in the SI (196 ± 23 vs 391 ± 64) and days 21 and 28 in N (141 ± 14 vs 357 ± 32 and 152 ± 28 vs 261 ± 20) groups, respectively but had no effect on the magnitude of enzymuria, despite significantly increased trough whole blood CsA levels (20-30{\%}) in both SI and N groups. These results indicate that calcium blockade reduces both structural and functional features of chronic CsA nephrotoxicity.",
keywords = "calcium blockade, cyclosporin A, nephrotoxicity, rat",
author = "Shaikh, {M. G.} and Heys, {S. D.} and Brown, {P. A.J.} and Whiting, {P. H.}",
year = "1993",
month = "8",
language = "English",
volume = "74",
pages = "389--396",
journal = "International journal of experimental pathology",
issn = "0959-9673",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Chronic cyclosporin A (CsA) nephrotoxicity in the rat

T2 - The effect of calcium blockade with verapamil

AU - Shaikh, M. G.

AU - Heys, S. D.

AU - Brown, P. A.J.

AU - Whiting, P. H.

PY - 1993/8

Y1 - 1993/8

N2 - Renal structure and function were assessed in groups of male Sprague-Dawley rats, either surgically intact (SI) or nephrectomized (N), treated with either CsA alone (20 mg/kg, p.o.) or in combination with verapamil (VER; 10 mg/kg/day, i.p.) daily for up to 28 days. Compared to vehicle treated controls, reduced creatinine clearance rates (CCR, mean ± s.e.m.) were noted following CsA treatment in SI animals on days 21 and 28 (279 ± 4 vs 196 ± 20 and 296 ± 13 vs 122 ± 13 ml/h/kg, respectively, both P < 0.05). However, CCR was around 60% of pretreatment values in all N animals from day 7 onwards. A two to three-fold elevation in urinary N-acetyl-β-D-glucosaminidase activity was noted from day 7 to 28 in all CsA treated animals. In addition, a similar severity of both renal tubular basophilia and corticomedullary microcalcification (but not proximal tubular vacuolation), was noted at all time points in animals receiving CsA alone. Co-treatment with VER reduced the severity of microcalcification in CsA groups, particularly N animals, increased CCR on day 14 in the SI (196 ± 23 vs 391 ± 64) and days 21 and 28 in N (141 ± 14 vs 357 ± 32 and 152 ± 28 vs 261 ± 20) groups, respectively but had no effect on the magnitude of enzymuria, despite significantly increased trough whole blood CsA levels (20-30%) in both SI and N groups. These results indicate that calcium blockade reduces both structural and functional features of chronic CsA nephrotoxicity.

AB - Renal structure and function were assessed in groups of male Sprague-Dawley rats, either surgically intact (SI) or nephrectomized (N), treated with either CsA alone (20 mg/kg, p.o.) or in combination with verapamil (VER; 10 mg/kg/day, i.p.) daily for up to 28 days. Compared to vehicle treated controls, reduced creatinine clearance rates (CCR, mean ± s.e.m.) were noted following CsA treatment in SI animals on days 21 and 28 (279 ± 4 vs 196 ± 20 and 296 ± 13 vs 122 ± 13 ml/h/kg, respectively, both P < 0.05). However, CCR was around 60% of pretreatment values in all N animals from day 7 onwards. A two to three-fold elevation in urinary N-acetyl-β-D-glucosaminidase activity was noted from day 7 to 28 in all CsA treated animals. In addition, a similar severity of both renal tubular basophilia and corticomedullary microcalcification (but not proximal tubular vacuolation), was noted at all time points in animals receiving CsA alone. Co-treatment with VER reduced the severity of microcalcification in CsA groups, particularly N animals, increased CCR on day 14 in the SI (196 ± 23 vs 391 ± 64) and days 21 and 28 in N (141 ± 14 vs 357 ± 32 and 152 ± 28 vs 261 ± 20) groups, respectively but had no effect on the magnitude of enzymuria, despite significantly increased trough whole blood CsA levels (20-30%) in both SI and N groups. These results indicate that calcium blockade reduces both structural and functional features of chronic CsA nephrotoxicity.

KW - calcium blockade

KW - cyclosporin A

KW - nephrotoxicity

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=0027258956&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 389

EP - 396

JO - International journal of experimental pathology

JF - International journal of experimental pathology

SN - 0959-9673

IS - 4

ER -